<SEC-DOCUMENT>0001628280-24-019030.txt : 20240429
<SEC-HEADER>0001628280-24-019030.hdr.sgml : 20240429
<ACCEPTANCE-DATETIME>20240429163605
ACCESSION NUMBER:		0001628280-24-019030
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20240429
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240429
DATE AS OF CHANGE:		20240429

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MEDIFAST INC
		CENTRAL INDEX KEY:			0000910329
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS [2090]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				133714405
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31573
		FILM NUMBER:		24891756

	BUSINESS ADDRESS:	
		STREET 1:		11445 CRONHILL DRIVE
		CITY:			OWINGS MILLS
		STATE:			MD
		ZIP:			21117
		BUSINESS PHONE:		7327640619

	MAIL ADDRESS:	
		STREET 1:		11445 CRONHILL DRIVE
		CITY:			OWINGS MILLS
		STATE:			MD
		ZIP:			21117

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHRITE INC
		DATE OF NAME CHANGE:	19951120

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XX
		DATE OF NAME CHANGE:	19950619

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	00
		DATE OF NAME CHANGE:	19950619
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>med-20240429.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:dd2706ff-4455-4d9f-89f6-4661cea823de,g:49011a0f-8b9a-4891-9703-bd3af30cf0c0,d:1fc2fe58a86040a48c703b150f06604a-->
<html xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>med-20240429</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-21">0000910329</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-22">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="med-20240429.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-29</xbrli:startDate><xbrli:endDate>2024-04-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-29</xbrli:startDate><xbrli:endDate>2024-04-29</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i1fc2fe58a86040a48c703b150f06604a_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">_____________________________________</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Securities Exchange Act of 1934</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported):&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">April 29, 2024</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">MEDIFAST, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(State or other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">jurisdiction of incorporation)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-31573</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Commission</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">File Number)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">13-3714405</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(I.R.S. Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identification No.)</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">100 International Drive</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Baltimore</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">Maryland</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">21202</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of Principal Executive Offices) (Zip Code)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant's telephone number, including area code:&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">410</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">581-8042</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">N/A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former Name or Former Address, if Changed Since Last Report)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:40.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.629%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-13">Common Stock, par value $0.001 per share</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-14">MED</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-2" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-15">New York Stock Exchange</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;General Instruction A.2. below):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:4.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:93.199%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-16">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-17">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-18">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-19">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR&#160;&#167;240.12b-2).</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:96.122%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.578%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:324pt;text-align:right;text-indent:-324pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-20">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/></tr></table></div><div id="i1fc2fe58a86040a48c703b150f06604a_7"></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.02.&#160;&#160;&#160;&#160;Results of Operations and Financial Condition.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April 29, 2024, Medifast, Inc. (the "Company") issued a press release announcing its earnings for the first quarter ended March 31, 2024.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A copy of the Press Release is being furnished as Exhibit 99.1 attached hereto and is incorporated by reference herein. This information is being furnished in this report and shall not be deemed to be "filed" for any purpose, including for the purpose of Section 18 of the Securities and Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1993, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.</span></div><div id="i1fc2fe58a86040a48c703b150f06604a_10"></div><div style="-sec-extract:summary;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01.&#160;&#160;&#160;&#160;Financial Statements and Exhibits.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:83.404%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Exhibits.</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline" href="medfinalearningsrelease042.htm">Medifast Announces First Quarter 2024 Financial Results </a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL Document)</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i1fc2fe58a86040a48c703b150f06604a_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Signature</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.145%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.847%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.708%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MEDIFAST, INC.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ James P. Maloney</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James P. Maloney</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: April 29, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>medfinalearningsrelease042.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i28accab64c8540bea5eae1f8d0bcb69b_35"></div><div style="min-height:72pt;width:100%"><div><img alt="image.jpg" src="image.jpg" style="height:69px;margin-bottom:5pt;vertical-align:text-bottom;width:197px"></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Medifast Announces First Quarter 2024 Financial Results </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">April 29, 2024</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">BALTIMORE &#8211; (</font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">BUSINESS WIRE</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">)--</font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Medifast</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> (NYSE&#58; MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, </font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">OPTA</font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VIA&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">, today reported results for the first quarter ended March 31, 2024.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">First Quarter 2024 </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:12.53pt">Revenue of $174.7 million, with revenue per active earning coach of $4,623</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:12.53pt">Independent active earning</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%"> OPTA</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VIA Coaches of 37,800</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:12.53pt">Net income of $8.3 million </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">(non-GAAP adjusted net income of $7.2 million)</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:12.53pt">Earnings per diluted share (&#34;EPS&#34;) of $0.76</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> (non-GAAP adjusted EPS of $0.66)</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:12.53pt">Cash, Cash Equivalents, and Investment Securities of $156.4 million with zero debt</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8220;Fast paced medical innovation is providing greater access to medical weight loss solutions than ever before. We are transforming our </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">OPTA</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VIA offer to include comprehensive support for consumers who wish to use GLP-1 medical weight loss solutions on their individual journeys to sustainable healthy lifestyles. It&#8217;s a market that is estimated by a recent BCG market study to have the potential to grow to $50B or more by 2030, and it&#8217;s one that we are uniquely positioned to capitalize on,&#8221; said Dan Chard, Chairman &#38; Chief Executive Officer. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8220;Our new model is highly differentiated from competitors, with a holistic approach including our habit-based and Coach guided solution along with nutrition products and community support. It will be supported by a reimagined framework for customer acquisition, with a new company-led national marketing campaign, enhancing both awareness of the benefits of our approach, and the visibility of our brand. While 2024 will be a year of investment for future growth, we believe the initiatives we are undertaking will be foundational in creating a platform for sustained company growth in the years ahead.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">First Quarter 2024 Results</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">First quarter 2024 revenue decreased 49.9% to $174.7 million from $349.0 million for the first quarter of 2023, primarily driven by a decrease in the number of active earning </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">OPTA</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VIA Coaches, </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">lower Coach productivity</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">, and a $9.1 million impact from a timing difference related to changes in the company&#8217;s sales order terms and conditions with its customers realized in the first quarter of 2023. The total number of active earning </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">OPTA</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VIA Coaches decreased 35.6% to 37,800 compared to 58,700 for the first quarter of 2023. The average revenue per active earning </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">OPTA</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VIA Coach was $4,623, compared to $5,945 for the first quarter last year, primarily driven by continued pressure on customer acquisition.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Gross profit decreased 48.3% to $127.3 million from $246.4 million for the first quarter of 2023. The decrease in gross profi</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">t was due to lower revenue, partially offset by efficiencies in inventory management and cost savings from Fuel for the Future initiatives</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">. Gross profit margin was 72.8% compared to 70.6% in the first quarter of 2023, primarily due to efficiencies in inventory management and cost savings from Fuel for the Future initiatives, partially offset by increased shipping costs.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Selling, general, and administrative expenses (&#8220;SG&#38;A&#8221;) decreased 38.1% to $119.4 million compared to $192.9 million for the first quarter of 2023. </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The decrease in SG&#38;A was primarily due to lower </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">OPTA</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VIA Coach compensation expense due to lower volumes and fewer active earning Coaches, partially offset </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><img alt="image.jpg" src="image.jpg" style="height:69px;margin-bottom:5pt;vertical-align:text-bottom;width:197px"></div></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">by market research and investment costs related to medically supported weight loss activities and costs for company-led acquisition initiatives. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">As a percentage of revenue, SG&#38;A increased 1,300</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> basis points </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">year-over-year to 68.3% of revenue, as compared to 55.3% for the first quarter of 2023. </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The increase in SG&#38;A as a percentage of revenue was </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">primarily due to market research and investment costs related to medically supported weight loss activities, loss of leverage on fixed costs due to lower sales volumes, and </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">costs for company-led acquisition initiatives. Non-GAAP adjusted SG&#38;A, which </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">excludes expenses to initiate and operationalize the LifeMD, Inc. (&#8220;LifeMD&#8221;) collaboration,</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> decreased 38.8% to </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">$118.0 million</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> and non-GAAP adjusted SG&#38;A as a percentage of revenue increased</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> 1,220 basis points year-over-year to 67.5%.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Income from operations decreased 85.2% to $7.9 million from $53.5 million in the prior year period. As a percentage of revenue, income from operations was 4.5% for the first quarter of 2024 compared to 15.3% in the prior-year period. </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Non-GAAP adjusted income from operations decreased </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">82.7%</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> to $</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">9.3</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> million. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Non-GAAP adjusted income from operations as a percentage of revenue was 5.3%, a decrease of 1,000 basis points from the year-ago period.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The effective tax rate was 28.2% for the first quarter of 2024 compared to 25.1% in the prior-year period. The increase in the effective tax rate from the three months ended March 31, 2023 was primarily driven by an increase in the tax shortfall for stock compensation and the rate impact of research and development tax credits, partially offset by the decrease in the limitation for executive compensation and various other miscellaneous items.</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> The non-GAAP effective tax rate was 28.7% as compared to 25.1% in the prior year period.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">In the first quarter of 2024, net income was $8.3 million, or $0.76 per diluted share, based on approximately </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">11.0 million shares </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">of common stock outstanding. In the first quarter of 2023, net income was $40.0 million, or $3.67 per diluted share, based on approximately 10.9</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> million shares</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> of common stock outstanding.</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> In the first quarter 2024, non-GAAP adjusted net income was $7.2 million, or $</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">0.66</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> per diluted share.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Capital Allocation and Balance Sheet</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The company&#8217;s balance sheet remains strong with $156.4 million in cash, cash equivalents and investment securities and no interest-bearing debt as of March 31, 2024 compared to $150.0 million in cash, cash equivalents and investment securities and no debt at December 31, 2023. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Outlook</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The company expects second quarter 2024 revenue to be in the range of $150 million to $170 million and second quarter 2024 diluted EPS to be in the range of $0.05 to $0.40. The EPS range excludes the costs related to the initiation of the LifeMD collaboration and any gains or losses from changes in the market price of the company&#8217;s LifeMD common stock investment.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Conference Call Information</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The conference call is scheduled for today, Monday, April 29, 2024 at 4&#58;30 p.m. ET. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast&#8217;s website at </font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">www.MedifastInc.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> or directly at </font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">https&#58;&#47;&#47;viavid.webcasts.com&#47;starthere.jsp&#63;ei&#61;1663236&#38;tp_key&#61;1b6e0e1efe</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> and will be archived online and available through  July 29, 2024. In addition, listeners may dial (877) 451-6152 to join via telephone. A telephonic playback will be available </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><img alt="image.jpg" src="image.jpg" style="height:69px;margin-bottom:5pt;vertical-align:text-bottom;width:197px"></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">from 8&#58;30 p.m. ET, April 29 2024, through May 6, 2024. Participants can dial (844) 512-2921 and enter passcode 13745406 to hear the playback.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">About Medifast</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.15pt;font-weight:700;line-height:125%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Medifast (NYSE&#58; MED) is the health and wellness company known for its habit-based and coach-guided lifestyle solution </font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">OPTA</font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VIA&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">, which provides people with a simple, yet comprehensive approach to help them achieve lasting optimal health and wellbeing. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">OPTA</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VIA's lifestyle plans deliver clinically proven health benefits as well as evidence-based tools, including scientifically developed products and a framework for habit creation reinforced by independent Coaches and Community support. As a physician-founded company with a 40+ year history, Medifast is a leader in the U.S. weight management industry. Through a collaboration with the national virtual primary care provider </font><font style="background-color:#ffffff;color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">LifeMD</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">OPTA</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VIA customers have access to board-certified affiliated clinicians and medications, such as GLP-1s, that support treatment plans for obesity and other health conditions. The company continues to innovate and build upon its scientific and clinical heritage to fulfill its mission of offering the world Lifelong Transformation, One Healthy Habit at a Time&#174;. Medifast was recognized in 2023 by Financial Times as one of </font><font style="background-color:#ffffff;color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The Americas' Fastest Growing Companies</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> and in 2022 as one of </font><font style="background-color:#ffffff;color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">America&#8217;s Best Mid-Sized Companies by Forbes</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">. For more information, visit </font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">MedifastInc.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> and </font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">OPTA</font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VIA.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> and follow </font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#64;Medifast</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> on X. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">MED-F</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Forward Looking Statements</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Please Note&#58; This release contains &#34;forward-looking statements&#34; within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally can be identified by use of phrases or terminology such as &#34;intend,&#34; &#34;anticipate,&#34; &#34;expect&#34; or other similar words or the negative of such terminology. Similarly, descriptions of Medifast's objectives, strategies, plans, goals, outlook or targets contained herein are also considered forward-looking statements. These statements are based on the current expectations of the management of Medifast and are subject to certain events, risks, uncertainties and other factors. Some of these factors include, among others, Medifast's inability to maintain and grow the network of independent </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">OPTA</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VIA Coaches&#59; Industry competition and new weight loss products, including weight loss medications, or services&#59; Medifast&#8217;s health or advertising related claims by our </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">OPTA</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VIA customers&#59; Medifast's inability to continue to develop new products&#59; effectiveness of Medifast's advertising and marketing programs, including use of social media by </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">OPTA</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VIA Coaches&#59; the departure of one or more key personnel&#59; Medifast's inability to protect against online security risks and cyberattacks&#59; risks associated with Medifast's direct-to-consumer business model&#59; disruptions in Medifast's supply chain&#59; product liability claims&#59; Medifast's planned growth into domestic markets including through its collaboration with LifeMD, Inc.&#59; adverse publicity associated with Medifast's products&#59; the impact of existing and future laws and regulations on Medifast&#8217;s business&#59; fluctuations of Medifast's common stock market price&#59; increases in litigation&#59; actions of activist investors&#59; the consequences of other geopolitical events, overall economic and market conditions and the resulting impact on consumer sentiment and spending patterns&#59; and Medifast's ability to prevent or detect a failure of internal control over financial reporting. Although Medifast believes that the expectations, statements and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its Annual Report on Form 10-K for the fiscal year ended December </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><img alt="image.jpg" src="image.jpg" style="height:69px;margin-bottom:5pt;vertical-align:text-bottom;width:197px"></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">31, 2023, and other filings filed with the United States Securities and Exchange Commission, including its quarterly reports on Form 10-Q and current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Contacts</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Investor Contact&#58;</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Medifast, Inc.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Steven Zenker</font></div><div><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">InvestorRelations&#64;medifastinc.com</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">(443) 379-5256</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><img alt="image.jpg" src="image.jpg" style="height:69px;margin-bottom:5pt;vertical-align:text-bottom;width:197px"></div></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">MEDIFAST, INC. AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(U.S. dollars in thousands, except per share amounts &#38; dividend data)</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.459%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.046%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.046%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.049%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Three Months Ended March 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">2024</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">2023</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Revenue</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">174,739&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$ 348,98</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:13.5pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Cost of sales</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">47,447</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">102,593</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">Gross profit</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">127,292</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">246,390</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:13.5pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Selling, general, and administrative</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">119,352</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">192,879</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">Income from operations</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">7,940</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">53,511</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Other income (expense)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:13.5pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Interest income (expense)</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">1,223</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">(181)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:13.5pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Other income (expense)</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">2,422</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">(1)</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">3,645</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">(182)</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">Income from operations before income taxes</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">11,585</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">53,329</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:13.5pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Provision for income taxes</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">3,269</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">13,361</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">Net income</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">$8,316</font></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">39,968</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Earnings per share - basic</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">0.76&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">3.68&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Earnings per share - diluted</font></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">0.76&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$</font></td><td style="padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">3.67&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">Weighted average shares outstanding</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Basic</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">10,909</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">10,864</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Diluted</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">10,958</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">10,899</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Cash dividends declared per share</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$ </font></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$</font></td><td style="border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">1.65&#160;</font></td><td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><img alt="image.jpg" src="image.jpg" style="height:69px;margin-bottom:5pt;vertical-align:text-bottom;width:197px"></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">MEDIFAST, INC. AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(U.S. dollars in thousands, except par value)</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.109%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.213%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">March 31, 202</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">December 31, 202</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">ASSETS</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">Current Assets</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:12pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Cash and cash equivalents</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">97,471&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$ 94,44</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:12pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Inventories</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">46,273</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">54,591</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:12pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Investments</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">58,957</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">55,601</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:12pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Income taxes, prepaid</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">5,471</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">8,727</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:12pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Prepaid expenses and other current assets</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">11,412</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">10,670</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">Total current assets</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">219,584</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">224,029</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Property, plant and equipment - net of accumulated depreciation</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">50,986</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">51,467</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Right-of-use assets</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">14,536</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">15,645</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Other assets</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">13,648</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">14,650</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Deferred tax assets</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">4,005</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">4,117</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">TOTAL ASSETS</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">302,759</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">309,908</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">LIABILITIES AND STOCKHOLDERS' EQUITY</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">Current Liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:12pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Accounts payable and accrued expenses</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">71,229&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">86,415&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:12pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Current lease obligations</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">5,958</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">5,885</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">Total current liabilities</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">77,187</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">92,300</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:12pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Lease obligations, net of current lease obligations</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">14,611</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">16,127</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">Total liabilities</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">91,798</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">108,427</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:6pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">Stockholders' Equity</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:12pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Common stock, par value $0.001 per share&#58; 20,000 shares authorized&#59;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">10,937 and 10,896 issued and outstanding</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">at March 31, 2024 and December 31, 2023, respectively</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">11</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">11</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:12pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Additional paid-in capital</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">27,963</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">26,573</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:12pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Accumulated other comprehensive income</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">22</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">248</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:12pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Retained earnings</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">182,965</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">174,649</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">Total stockholders' equity</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">210,961</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">201,481</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">302,759</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:114%">309,908</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><img alt="image.jpg" src="image.jpg" style="height:69px;margin-bottom:5pt;vertical-align:text-bottom;width:197px"></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Non-GAAP Financial Measures</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">In an effort to provide investors with additional information regarding the company&#8217;s results,  the company discloses various non-GAAP financial measures in its quarterly earnings press release and other public disclosures. The following GAAP financial measures have been presented on an as adjusted basis&#58; SG&#38;A expenses, income from operations, other income (expense), provision for income taxes, net income and diluted EPS. Each of these non-GAAP financial measures excludes the impact of certain amounts to initiate and operationalize the LifeMD collaboration and unrealized gains on investment in LifeMD common stock as further identified below and have not been calculated in accordance with GAAP. A reconciliation of each of these non-GAAP financial measures to its most comparable GAAP financial measure is included below. These non-GAAP financial measures are not intended to replace GAAP financial measures.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The company uses these non-GAAP financial measures internally to evaluate and manage the company's operations because it believes they provide useful supplemental information regarding the company's on-going economic performance. The company has chosen to provide this information to investors to enable them to perform more meaningful comparisons of operating results and as a means to emphasize the results of on-going operations.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The following tables reconcile the non-GAAP financial measures included in this release&#58;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><img alt="image.jpg" src="image.jpg" style="height:69px;margin-bottom:5pt;vertical-align:text-bottom;width:197px"></div></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">MEDIFAST, INC. AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED NON-GAAP (UNAUDITED)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(U.S. dollars in thousands, except per share amounts)</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.611%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.652%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Three months ended March 31, 2024</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">GAAP</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Unrealized Gain on Investment in LifeMD Common Stock</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">LifeMD Prepaid Services Amortization</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Non-GAAP</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Selling, general, and administrative</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">$ 119,35</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">$ </font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">(1,327)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">118,025&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Income from operations</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">7,940</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">1,327</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">9,267</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Other income (expense)</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">3,645</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">(2,841)</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">804</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Provision for income taxes</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">3,269</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">(710)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">332</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">2,891</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Net income</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">8,316</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">(2,130)</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">995</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">7,181</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Diluted earnings per share </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.15pt;font-weight:400;line-height:125%;position:relative;top:-3.85pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">0.76</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">(0.19)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">0.09</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">0.66</font></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Three Months Ended March 31, 2023</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">GAAP</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Unrealized Gain on Investment in LifeMD Common Stock</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">LifeMD Prepaid Services Amortization</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Non-GAAP</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Selling, general, and administrative</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">$ 192,87</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">$ </font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">$ </font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">$ 192,87</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Income from operations</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">53,511</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">53,511</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Other income (expense)</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">(182)</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">(182)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Provision for income taxes</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">13,361</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">13,361</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Net income</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">39,968</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">39,968</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Diluted earnings per share </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.15pt;font-weight:400;line-height:125%;position:relative;top:-3.85pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">3.67</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">3.67</font></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1) The weighted-average diluted shares outstanding used in the calculation of these non-GAAP financial measures are the same as the weighted-average shares outstanding used in the calculation of the reported per share amounts.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>med-20240429.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:dd2706ff-4455-4d9f-89f6-4661cea823de,g:49011a0f-8b9a-4891-9703-bd3af30cf0c0-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:med="http://www.medifast1.com/20240429" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.medifast1.com/20240429">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/exch/2024" schemaLocation="https://xbrl.sec.gov/exch/2024/exch-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="med-20240429_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="med-20240429_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="med-20240429_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.medifast1.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>med-20240429_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:dd2706ff-4455-4d9f-89f6-4661cea823de,g:49011a0f-8b9a-4891-9703-bd3af30cf0c0-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.medifast1.com/role/Cover" xlink:type="simple" xlink:href="med-20240429.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.medifast1.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_3f1e8cc3-9d14-43ee-9a2f-4d64bce75fd0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_EntitiesTable_3f1e8cc3-9d14-43ee-9a2f-4d64bce75fd0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_19128bed-a3ba-4aca-a885-4aa817066d49" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityListingsExchangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_3f1e8cc3-9d14-43ee-9a2f-4d64bce75fd0" xlink:to="loc_dei_EntityListingsExchangeAxis_19128bed-a3ba-4aca-a885-4aa817066d49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_19128bed-a3ba-4aca-a885-4aa817066d49_default" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityListingsExchangeAxis_19128bed-a3ba-4aca-a885-4aa817066d49" xlink:to="loc_dei_ExchangeDomain_19128bed-a3ba-4aca-a885-4aa817066d49_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_9235ee56-ab59-456d-8261-61f5f00e708f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityListingsExchangeAxis_19128bed-a3ba-4aca-a885-4aa817066d49" xlink:to="loc_dei_ExchangeDomain_9235ee56-ab59-456d-8261-61f5f00e708f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS_1619da53-1e8c-418b-a020-a94419d3ec87" xlink:href="https://xbrl.sec.gov/exch/2024/exch-2024.xsd#exch_XNYS"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain_9235ee56-ab59-456d-8261-61f5f00e708f" xlink:to="loc_exch_XNYS_1619da53-1e8c-418b-a020-a94419d3ec87" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_75128dc1-83bc-4a45-b57c-4b79ebdb252d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_DocumentType_75128dc1-83bc-4a45-b57c-4b79ebdb252d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_5aedbcba-9966-4669-a1d5-c41e29e65d9d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_DocumentPeriodEndDate_5aedbcba-9966-4669-a1d5-c41e29e65d9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_063363e4-b35d-4492-864f-61e129919f48" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_EntityRegistrantName_063363e4-b35d-4492-864f-61e129919f48" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_66de949c-bd15-4e27-8cb8-6d0ee167979f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_EntityAddressAddressLine1_66de949c-bd15-4e27-8cb8-6d0ee167979f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_b7bffee0-3e56-414a-92be-5c2a1fac32bf" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_EntityAddressCityOrTown_b7bffee0-3e56-414a-92be-5c2a1fac32bf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_c001a1d3-2d39-4a74-9539-4d43d883d0ee" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_EntityAddressStateOrProvince_c001a1d3-2d39-4a74-9539-4d43d883d0ee" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_4c829023-2c2a-4bac-9501-704fc4ebdda6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_EntityAddressPostalZipCode_4c829023-2c2a-4bac-9501-704fc4ebdda6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_62f4b7a8-b694-4eba-9100-e61c6a245043" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_CityAreaCode_62f4b7a8-b694-4eba-9100-e61c6a245043" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_c4971b0f-78ed-4bd7-9d55-a31c334686a8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_LocalPhoneNumber_c4971b0f-78ed-4bd7-9d55-a31c334686a8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_2146f25b-c886-4376-b1f9-1666051f2d76" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_Security12bTitle_2146f25b-c886-4376-b1f9-1666051f2d76" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_0282bf2f-3b34-465e-9ea7-2e116ac0d80c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_TradingSymbol_0282bf2f-3b34-465e-9ea7-2e116ac0d80c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_fa25d0f3-0534-45d9-b0cd-6aa1ebf73afb" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_SecurityExchangeName_fa25d0f3-0534-45d9-b0cd-6aa1ebf73afb" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_cc8dd2d2-c3c6-4255-a8bb-9b2f266b39e2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_WrittenCommunications_cc8dd2d2-c3c6-4255-a8bb-9b2f266b39e2" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_8365652a-662a-49ef-8b50-92fd0c4b35ad" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_SolicitingMaterial_8365652a-662a-49ef-8b50-92fd0c4b35ad" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_88cdedbb-3ace-46f8-898c-9da3fa2f5c57" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_PreCommencementTenderOffer_88cdedbb-3ace-46f8-898c-9da3fa2f5c57" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_c2725426-290b-42ab-8b71-c9df8340a782" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_c2725426-290b-42ab-8b71-c9df8340a782" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_c0f213f8-8368-415a-84a8-371e86a41530" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_EntityEmergingGrowthCompany_c0f213f8-8368-415a-84a8-371e86a41530" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_42652f3f-207f-49ec-bc8d-1100856c8a41" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_EntityCentralIndexKey_42652f3f-207f-49ec-bc8d-1100856c8a41" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_13014c24-1452-4a1a-b8e1-6a5f2f82efad" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_AmendmentFlag_13014c24-1452-4a1a-b8e1-6a5f2f82efad" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_21619154-82b4-4222-9eab-8ffc11145cca" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_EntityTaxIdentificationNumber_21619154-82b4-4222-9eab-8ffc11145cca" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_9fcf6941-7563-4b9f-993d-406c31541062" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_EntityFileNumber_9fcf6941-7563-4b9f-993d-406c31541062" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_d04cc6ab-bff6-4f73-8d2c-97bd34434006" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_EntityIncorporationStateCountryCode_d04cc6ab-bff6-4f73-8d2c-97bd34434006" xlink:type="arc" order="21"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>med-20240429_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:dd2706ff-4455-4d9f-89f6-4661cea823de,g:49011a0f-8b9a-4891-9703-bd3af30cf0c0-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_72824883-f876-4a1c-9340-27cd2b12414d_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_e5233807-d3d3-4d20-a0ae-46fb8e41155d_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityListingsExchangeAxis_1456d92e-813e-40dd-86a7-e8883eed00a5_terseLabel_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:label id="lab_dei_EntityListingsExchangeAxis_label_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityListingsExchangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityListingsExchangeAxis" xlink:to="lab_dei_EntityListingsExchangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_7103ed39-7c56-491b-a696-866a8da4c23a_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_9cde37fc-203a-4659-a926-c9b029d4f7fe_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_c9f5a69c-b007-4d21-ac7a-d2dd46d4c8d7_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_8ff5268c-f3c7-4df9-8320-26ad7fa74fc9_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_0a3afa01-413b-45ed-9707-63d08c573dea_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_146140c4-f0bd-41eb-9dd1-dde87e7d774b_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_d4e9ff7f-2be0-4e7c-951a-fe0fd94ecb73_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_21df2d25-9305-4e5f-8adc-ad3aa83e7199_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_ad4707e2-8986-4d8a-a04d-c9f27491b53f_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_42f8d496-f66d-4d83-96a3-9be8a1f10d64_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_exch_XNYS_4abf3a29-706d-45fb-8f7d-1873963b8c17_terseLabel_en-US" xlink:label="lab_exch_XNYS" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">NEW YORK STOCK EXCHANGE, INC.</link:label>
    <link:label id="lab_exch_XNYS_label_en-US" xlink:label="lab_exch_XNYS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NEW YORK STOCK EXCHANGE, INC. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS" xlink:href="https://xbrl.sec.gov/exch/2024/exch-2024.xsd#exch_XNYS"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exch_XNYS" xlink:to="lab_exch_XNYS" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_af39846c-f6a8-4d86-85de-3d0c48935b37_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_7cfe9f7f-ee92-41c4-b747-fc02d9a0a709_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_472fd19f-8264-495e-b73c-2cbfa34f7e5e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_2e6f8f2f-428a-42b6-bbc4-c952bd9e08ea_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_6708b58d-e7df-4489-a234-a2cf1c8d99f5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_60034048-f899-487f-afb8-4f8a410f6581_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_778d191e-646f-4339-9f5d-db014d45202c_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_26e14aca-3df2-410a-8f68-ce53300bb291_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_ExchangeDomain_118bf3c1-c427-499e-bc1d-951291e72aaf_terseLabel_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:label id="lab_dei_ExchangeDomain_label_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ExchangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ExchangeDomain" xlink:to="lab_dei_ExchangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_920f88fa-2e98-4925-99b3-b599abc5d210_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_c0c0001e-3830-4f4a-8b89-2c2614e0b2cb_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_cc8fd574-22e2-49f2-8004-86c50e53f00a_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_e29dd4be-533e-473d-9844-5a8e483fb52e_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>med-20240429_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:dd2706ff-4455-4d9f-89f6-4661cea823de,g:49011a0f-8b9a-4891-9703-bd3af30cf0c0-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.medifast1.com/role/Cover" xlink:type="simple" xlink:href="med-20240429.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_19a6c9b0-b2bc-45fe-9596-dffba1b0b65c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_3f1e8cc3-9d14-43ee-9a2f-4d64bce75fd0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19a6c9b0-b2bc-45fe-9596-dffba1b0b65c" xlink:to="loc_dei_EntitiesTable_3f1e8cc3-9d14-43ee-9a2f-4d64bce75fd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_19128bed-a3ba-4aca-a885-4aa817066d49" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityListingsExchangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_3f1e8cc3-9d14-43ee-9a2f-4d64bce75fd0" xlink:to="loc_dei_EntityListingsExchangeAxis_19128bed-a3ba-4aca-a885-4aa817066d49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_9235ee56-ab59-456d-8261-61f5f00e708f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ExchangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityListingsExchangeAxis_19128bed-a3ba-4aca-a885-4aa817066d49" xlink:to="loc_dei_ExchangeDomain_9235ee56-ab59-456d-8261-61f5f00e708f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS_1619da53-1e8c-418b-a020-a94419d3ec87" xlink:href="https://xbrl.sec.gov/exch/2024/exch-2024.xsd#exch_XNYS"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_ExchangeDomain_9235ee56-ab59-456d-8261-61f5f00e708f" xlink:to="loc_exch_XNYS_1619da53-1e8c-418b-a020-a94419d3ec87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_3f1e8cc3-9d14-43ee-9a2f-4d64bce75fd0" xlink:to="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_75128dc1-83bc-4a45-b57c-4b79ebdb252d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_DocumentType_75128dc1-83bc-4a45-b57c-4b79ebdb252d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_5aedbcba-9966-4669-a1d5-c41e29e65d9d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_DocumentPeriodEndDate_5aedbcba-9966-4669-a1d5-c41e29e65d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_063363e4-b35d-4492-864f-61e129919f48" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_EntityRegistrantName_063363e4-b35d-4492-864f-61e129919f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_66de949c-bd15-4e27-8cb8-6d0ee167979f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_EntityAddressAddressLine1_66de949c-bd15-4e27-8cb8-6d0ee167979f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_b7bffee0-3e56-414a-92be-5c2a1fac32bf" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_EntityAddressCityOrTown_b7bffee0-3e56-414a-92be-5c2a1fac32bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_c001a1d3-2d39-4a74-9539-4d43d883d0ee" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_EntityAddressStateOrProvince_c001a1d3-2d39-4a74-9539-4d43d883d0ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_4c829023-2c2a-4bac-9501-704fc4ebdda6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_EntityAddressPostalZipCode_4c829023-2c2a-4bac-9501-704fc4ebdda6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_62f4b7a8-b694-4eba-9100-e61c6a245043" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_CityAreaCode_62f4b7a8-b694-4eba-9100-e61c6a245043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_c4971b0f-78ed-4bd7-9d55-a31c334686a8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_LocalPhoneNumber_c4971b0f-78ed-4bd7-9d55-a31c334686a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_2146f25b-c886-4376-b1f9-1666051f2d76" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_Security12bTitle_2146f25b-c886-4376-b1f9-1666051f2d76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_0282bf2f-3b34-465e-9ea7-2e116ac0d80c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_TradingSymbol_0282bf2f-3b34-465e-9ea7-2e116ac0d80c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_fa25d0f3-0534-45d9-b0cd-6aa1ebf73afb" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_SecurityExchangeName_fa25d0f3-0534-45d9-b0cd-6aa1ebf73afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_cc8dd2d2-c3c6-4255-a8bb-9b2f266b39e2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_WrittenCommunications_cc8dd2d2-c3c6-4255-a8bb-9b2f266b39e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_8365652a-662a-49ef-8b50-92fd0c4b35ad" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_SolicitingMaterial_8365652a-662a-49ef-8b50-92fd0c4b35ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_88cdedbb-3ace-46f8-898c-9da3fa2f5c57" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_PreCommencementTenderOffer_88cdedbb-3ace-46f8-898c-9da3fa2f5c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_c2725426-290b-42ab-8b71-c9df8340a782" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_c2725426-290b-42ab-8b71-c9df8340a782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_c0f213f8-8368-415a-84a8-371e86a41530" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_EntityEmergingGrowthCompany_c0f213f8-8368-415a-84a8-371e86a41530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_42652f3f-207f-49ec-bc8d-1100856c8a41" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_EntityCentralIndexKey_42652f3f-207f-49ec-bc8d-1100856c8a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_13014c24-1452-4a1a-b8e1-6a5f2f82efad" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_AmendmentFlag_13014c24-1452-4a1a-b8e1-6a5f2f82efad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_21619154-82b4-4222-9eab-8ffc11145cca" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_EntityTaxIdentificationNumber_21619154-82b4-4222-9eab-8ffc11145cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_9fcf6941-7563-4b9f-993d-406c31541062" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_EntityFileNumber_9fcf6941-7563-4b9f-993d-406c31541062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_d04cc6ab-bff6-4f73-8d2c-97bd34434006" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c9894771-befc-4a88-b4eb-b8ea18c74c99" xlink:to="loc_dei_EntityIncorporationStateCountryCode_d04cc6ab-bff6-4f73-8d2c-97bd34434006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image.jpg
<TEXT>
begin 644 image.jpg
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M!-Q%WYU [<:]4*49P<2@.VK\,N.1P-3OXU5XNB[=OK!,LQ0"A6B\Q+KO#UF
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M#_UY"GZ %Q32H&8I!(KN#BBT)%NEZ2!;L:I% 7PV,!JU!3Y:G&IU/L0?/HC
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MPBC(H5$8L'B3N4$:L:(B*0(MMRJNT).B&N47Q\_C?]*M"Z!+6"4P'1U'+;5
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M?,.80J (("@J4%/&4MMKLD63^A+U!DKOL>C7BT;2?GNN7,-K71,8BT0QP(]
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FR0\*?_*GAY(?%/[D3]]+P/\"T78;DKZ")#(     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139882809803744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Apr. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr. 29,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MEDIFAST, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">100 International Drive<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Baltimore<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">21202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">410<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">581-8042<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MED<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000910329<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3714405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-31573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsExchangeAxis=exch_XNYS', window );">NEW YORK STOCK EXCHANGE, INC.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=exch_XNYS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=exch_XNYS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( (&$G5@'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " "!A)U8$6S7_.X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M:L,P#(9?9?B>R'%*82;-9:6G#08K;.QF;+4UBQ-C:R1]^SE>FS*V!]C1TN]/
MGT"-]E(/ 9_#X#&0Q7@WN:Z/4OL-.Q%Y"1#U"9V*94KTJ7D8@E.4GN$(7ND/
M=400G*_!(2FC2,$,+/Q"9&UCM-0!%0WA@C=ZP?O/T&68T8 =.NPI0E56P-IY
MHC]/70,WP PC#"Y^%] LQ%S]$YL[P"[)*=HE-8YC.=8YEW:HX.WI\26O6]@^
MDNHUIE_12CI[W+#KY-?Z8;O?L59PL2KXJA#W>\%EO99<O,^N/_QNPFXP]F#_
ML?%5L&W@UUVT7U!+ P04    " "!A)U8F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M (&$G5CU)!OR> 0  .D1   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MK9AA;^HV%(;_BI5-TR:U)0[0T@Z0:*#WHMY25-BZNVD?3&+ :A+GVDYI__V.
M0YHP+9RT5^,#Q$G.R^/CD]=V^CNIGO26<T->XBC1 V=K3'K5:NE@RV.FSV3*
M$[BREBIF!IIJT]*IXBS,@^*HY;GN>2MF(G&&_?S<7 W[,C.12/A<$9W%,5.O
MUSR2NX%#G;<3#V*S-?9$:]A/V88ON/DMG2MHM4J54,0\T4(F1/'UP!G1JVOO
MW ;D=_PN^$X?'!/;E9643[8Q#0>.:XEXQ -C)1C\/'.?1Y%5 HYOA:A3_J<-
M/#Q^4[_).P^=63'-?1D]BM!L!T[/(2%?LRPR#W+WF1<=ZEJ]0$8Z_R:[_;V=
MCD."3!L9%\% $(MD_\M>BD0<!M C 5X1X.7<^S_**<?,L&%?R1U1]FY0LP=Y
M5_-H@!.)'96%47!50)P9^O*9JW[+@)0]T0J*L.M]F'<D;)2J,^)=GA#/]3K_
M#F\!08GAE1A>KM<^HC=)C#"O9)KLZ\R.UU]?X!XR-3S6?]<![@4[]8*VF*]T
MR@(^<*!:-5?/W!G^] ,]=W]%<-LE;AM3'XYED$%I&K)\37D='![>.[U%(#HE
M1.=]$'.NA S)) D)U$ M#ZY4CF;3<'9+M"XJ6 SG ]\(;10#QAF+:\%PG;O)
M>'HS6BQ/R'3FGR%@YR78^7O 1F$(1:%/W@Y(7FOW22TBKDA=%\K6<)7D9<LB
M,E;@,PCK1<EZ\2%6W[:D(DNY2^HX<;5K%AD12X61]4JRWH?(%@;*SJ+-E7P6
M25";1ESR;HQP799<EQ_BFDMM8$#^%"GQ95A+A0MZ%!X(!(RZE<VZJ%(^>".8
M-X^2- ATJ(N!'/@]176^R !2,M]**/A9%J^.N#\NTNW1TY[;05-363]%K7JX
M%":"ZED3ZOV\^H4L>) IR%8M%J[DRSB&F6-A9/!T0E*FR#.+,DY^=,]<EY*4
MPW)DR]!'@%93 ,5-?*E8*)(-6;S&*QG5TN("8&X82#4-4-R]'R%;AB?$]CY+
M1)#[D*X%PH76+-)H;BK[I[AO+V0D F%L>N[ &I1@]0G"51IY*M>GN$G/%3\-
M(#T<O&D_;_,DA&JX7Z^/U#^NUTA6>3S%;?D_9%.M,R!K!,1E&P$KJZ?O\OI)
MS-7&CN<G4#!;6VPI2^H?4ERP$:UR>_HNN_<A;0H\;0H9>R&WO!X*EW+A<TG=
MMG>)+68KM_=PLQ[!4(;Y<-Y$;%.[>L4%FI+D57[OX59=)&G)7L@T!"*Q+AP"
M<?\&2=H^;5_03L?M8H0'2W_<M0O"&Q%A,U*#"/C[:9MV+]H84N7M'F[-Y78D
MD"J5*L_7P3+'EQF4W.O1J;Q!?3S!("O?]W"[GDT>R=?[AUNR6-[[MV3RA_]Y
M-/LTJ5LK%UBHWG=NF;QJ4O"Z__L>#YT@OI>XFC8\W.;?EB)D\A)L6;+A1[<Q
M#4*SKXO:,6\=;-SM2Y [9DU6DXBO0<<]NX#^J_U[A7W#R#3?RZ^D,3+.#[><
MP4QA;X#K:RG-6\.^'BC?[@S_ 5!+ P04    " "!A)U8GZ ;\+$"  #B#
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M#ZP+V.Q _G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X
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MTZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0
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MBBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @
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MX3]>?P%02P$"% ,4    " "!A)U8!T%-8H$   "Q    $
M@ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( (&$G5@1;-?\[@
M "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4
M Q0    ( (&$G5B97)PC$ 8  )PG   3              "  <P!  !X;"]T
M:&5M92]T:&5M93$N>&UL4$L! A0#%     @ @82=6/4D&_)X!   Z1$  !@
M             ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4
M Q0    ( (&$G5B?H!OPL0(  .(,   -              "  ;L,  !X;"]S
M='EL97,N>&UL4$L! A0#%     @ @82=6)>*NQS     $P(   L
M     ( !EP\  %]R96QS+RYR96QS4$L! A0#%     @ @82=6*K$(A8S 0
M(@(   \              ( !@!   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0
M   ( (&$G5@D'INBK0   /@!   :              "  > 1  !X;"]?<F5L
M<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( (&$G5AED'F2&0$  ,\#
M   3              "  <42  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@
0   )  D /@(   \4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="med-20240429.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="med-20240429.htm">med-20240429.htm</File>
    <File>med-20240429.xsd</File>
    <File>med-20240429_def.xml</File>
    <File>med-20240429_lab.xml</File>
    <File>med-20240429_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "med-20240429.htm": {
   "nsprefix": "med",
   "nsuri": "http://www.medifast1.com/20240429",
   "dts": {
    "inline": {
     "local": [
      "med-20240429.htm"
     ]
    },
    "schema": {
     "local": [
      "med-20240429.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/exch/2024/exch-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "med-20240429_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "med-20240429_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "med-20240429_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 28,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 22
   },
   "report": {
    "R1": {
     "role": "http://www.medifast1.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "med-20240429.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "med-20240429.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitiesTable",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entities [Table]",
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Information [Line Items]",
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Listings, Exchange [Axis]",
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange [Domain]",
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "exch_XNYS": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/exch/2024",
     "localname": "XNYS",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NEW YORK STOCK EXCHANGE, INC.",
        "label": "NEW YORK STOCK EXCHANGE, INC. [Member]"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001628280-24-019030-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-24-019030-xbrl.zip
M4$L#!!0    ( (&$G5A\JM/';0\  $9I   0    ;65D+3(P,C0P-#(Y+FAT
M;>T=VW;B./)]OD++7CHY)S:^08 DS&%H,LM.Y[(A<V9V7^8(6PZ:-C8CBP#[
M]5LEV02"2: ['<ATYR$=6W*I[JHJ7?KT^^DP(O=,I#R)S][9IO6.L-A/ A[?
MG;UK]=K=[KOOF]^=_L4P?OWAY@-YG_CC(8LE:0M&)0O(A,L!D0-&?DG$1WY/
MR75$99B(H6'HS]K):";XW4 2QW*\O%O>*AI!X!Q;U3 T/*]2,;R@'AJU>E@U
MO&K5]AFM.6[ CNX:7MVR;6I!8[].#:]6MXWZL>4:_<"EH6OYH>5;1T'##GTG
M9)4:K54MSZ)>S8=.?;MBA585WNAQ!Q)H!KKCM,&F_N"L-)!RU"B7IWT1F2GS
MS;ODOHPM942YE'6->/QQWG4RF9BJ>R+NH)?EEK&Y3U.6=P\8+P8,#4MPL9$_
M 9C'J:2QGP->ZCEQ53^[7J^7ITC6'.@*MDM=L75Q_. 1KMG@U;)NS+ORJ32
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MY&%4''$EKB$ZXFK5<L/@J0XI$Q6SB,;!8UP^%97K!,:*_LM'.HK+REM6J>F
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M@D44-X2N7)+Q0*ZBTWKXA/;3)!K+]9^L6[-:?^.&_CT0#Q9TQXR^8/2C04,
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M;=\V)>R.^W@A;= @CR^8W=C+?1+?WFZ:4M;_6XOZ'UZ:_P=02P,$%     @
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M_7U7Q!.A/IZCMP3"<B?L^73-1R#^\\MGR]/I1_IGO)?/_@=02P,$%     @
M@82=6,;LBC+I"P  [60  !0   !M960M,C R-# T,CE?;&%B+GAM;,5=77/;
M-A9]SZ_@>E]V9X(8!$$2R#3I9%VW]=1U,K$[33>SHP'Q87,JB1Z*CNU_OP#U
M8=$$)0*TF!='EJ[ON>>*AP> (.2''Q]FT^";+!=Y,7]W%+Z!1X&<\T+D\^MW
M1W]<_0S(T8_O7[WZX1\ ?/G/Y_/@IX+?S>2\"DY*R2HI@ON\N@FJ&QG\691_
MY]]8\&G**E64,P#>UW]V4MP^EOGU314@B/ Z;/UJ^58(E,)$*8!Q' ,LJ *$
MJ@3@) FY9 1%0KZ^?HLI#$,&]8L990 3&@*:P@AD(F(J@EQ!#NNDTWS^]UOS
M(V,+&6AZ\T7]Z[NCFZJZ?7M\?']__^8A*Z=OBO+Z&$$8':^CCU;A#ZWX^ZB.
M#BFEQ_6KF]!%;@O4:</C+[^?7_(;.6,@GR\J-N<&8)&_7=1/GA><5777]]85
M=$:8W\ Z#)BG0(A %+YY6(BC]Z^"8-F.LIC*SU(%YM\_/I]U0M)C$W$\E]?F
MO?TDR[P0EQ4KJW.6R:FNOLY6/=[*=T>+?'8[E>OG;DJI[&FG9=G(:JJDILHP
M,57^LPOL>$#Y+U1OU:[U!8JKZ5Z\5(V[>GKQ8N5>Z3N$/'S!6S"#2UY>4*=S
M,=:UNX$:7/KA*WZIRZ*HV'2$R^()9JODJ7GB7#]:P9A$.VZF-<[JUKU5JGRH
MY%S(Y=VRD3K(Q;LC_6@B9#XYG5=Y]7BFK;&\+<KZQJWO594\*>[F5?EX4@@Y
M21%!F) (*))J_V(A!S3"$*"4"Y2%"(=83*K-)3Z1<_#'Y;J:&M()[\B!=]6A
MWU(NBKN2+YU/UV!<?UG6^V4%0:.$UT%=1%"4P:J0P%3RP_$3A>%MG([=G.GH
M?2EX VUJA@)%^9QMP5W9/BEMH>G65!>2O[DNOAWK3,=F &8> /.@%EC?_,>M
MM_5#N>; 2KZGRZN(8U[H,=!M!1H-5V4Q\R);%5Y7Q++ENJ0C_78)6>I1KX5>
M^ZK-Y>**95,YD3&*(@)3("(1Z0$K@H!!)O6 565$XC",8S>9KS./(6B-%7RM
MT?[GJ-H-_Y[Z]&'EH<0^A-SE]KQX?V%M,HTKH><$6F)I!7C*XO$\7U1ZMK@X
M?> W^MV1'Q[RQ23$<2(HDH"$D58&% *0A*5 $NV/4@H(6>QFA3:8<1QPC?PZ
M6&,'7PVZJX#LG>KK=D/Y>YF<.W4/9]O%;("A6=..[&.[J+7M:V>TNSPO);\K
M==IUN@LVTV/4$$921!2D/-9C5!IF@"4TT>I,&!$,<Q2QOL*T 1Q8DFO(I^O1
M@/87HK4G^R4XE*F;^!Q).DEN%Q,OL5D3CB:S772V!;8SSM?Y/@BAW\7%B7[X
ML;PJ[N<3RH6,4L5UBR*F!X0Q!8RB!'":040%5JF2;K;7PAC'\U:PKP,#;*8U
M!MK5[]K]Z6MV@UA[.9T;80^7ZZ0TP.+:.4?VMTY2;7/K#O5PMF*:\]QXY>]Z
MCE?F;#KA5,7:R#C(H)Z9Z4E9"!A/&1!(")P(S(E(>_M:*_VA76T#&*P1'2RM
MW8P>AC:(HJ.=.;!S\[).$GY.UDXWGH]U4FFX6'>4NXA.BF^R_) MJI+QJL<E
MTX@_W-52P^A9Q@KHA68:UN*]KI)FIM$N$"N![6O#'N!Q69A[=2E9O11+E(I1
M0CA0$3=W544!B1 $*&$B52S%BM.^=]7MQ >^G]8>;K <5Z<;W'LHPI.1HR#Z
MD7&3@Z5R/S5L)QI/#);R&UJPO>X[RK]B#V="ZH<J7WY@?W$WRV0Y@2QBBL$0
MX##* (ZE,!L24I!$ A(>IY&0O6?2.Y'&&?%K\*")'BSA74?]7?WJ._9_@2YX
MS0#<&^ Q"]A#;L!<H"OSR#."/03;\X)]?^ NVP\S.1=FC]+/4W8]"7$28L@Q
M4# 36JLR U2($ @A22I3D:8XZRO31N8#RW*#%1BP_B)LLM\O.F].;B+K2<=)
M4M;2O234S#2:9*P$MB5B#W"7Q%7)S(Z^R\=95DPG DNJ5*H RB0$6*8<T#AD
M0$FH!,629VG45Q*-S >6Q HK6(+UET23_7Y)>'-RDT1/.DZ2L);N)8EFIM$D
M826P+0E[@._@[K.\SLV4:5[5GP2@4"@D4 QH!&.MC%@!P@0'3$2,D4BF(>T]
MW[$!C#.4>\)T_'3$VI.^XS9_IE[#M;XD/09I=B8#QF;/$HX\)+/3:8_$.N+<
MI?6IE"?%3-L6E\:[KLS^NO*C4GH2P 36<R2) *$D 5@0!AC$ G"J4&H^C8PC
MU5=@W3 'EID&!GP+.5A"!S5V?[7M:--^S;T,>3?E^?%V$N!^6EXRW)%V-#'N
MI[8MR1[1OIYW.I/EM;;07\KBOKK1*+=L_CC!2!&!:0)4D@BCS C0A.D?F20L
M5"$4"7:S/BO.. ZXA@Z6V,$*W-4)[9WJ:XB#^7OYHBMU#W_<26R 3=KSCNR6
M.\FU37-WN)M$Y0._F7RY^.MR@EFF(H8H2*$18ZPR0%0J0$C2B"911GC8Z]/,
M3<8#R^[B],_@KX^??PLNKSZ>_!:<?CGY]</%+Z>O@[.+DS?]5/=$?K>^O"BY
M*6DGF^#K[](L4+W !U,M*CNT8V*7XC&/GM3SE&,4G;1*7BNB_8*O/9UHNRO9
M]$P;WL-O\G'"5$0)3K@V)D:,,26 Q$*"2$"."8WB+.K]R;X581Q+6H$&-6J@
M85W-Z'E?^MK0 +9>!M2?J(?U=) 98#K/,XYL-QV$VD;3%>@KLY_SJ5Q],I-R
M):E9#Y22(H!#CD&6XA0H#I&@#+(4.JYZ/"4?1UP&S_/CJJT^]%64'SLO,?4A
MYB&C-H,!"MI*-K)XVC3:NK'$#-SO67^QZ&/YJ2R^Y;K0"4Z1$J'YVCI*,, T
MEEH^$0>(9XI%6*4R]MOT^0QH'"EM-D)NOM&VQO?<_OF\77U5-KP)7HKSX.^_
M&[2#W/ MH<\3?Y]]H1WT.C>'=L4/7H(\6RSN9+F]PH9DHHA""F!$F/Z1)2#+
MM/%Q&J-,4 E)_]T;^\#&7HY<%O RJY+MSCFO30[JQ\ 52I=6#%FH[.3X$LN5
M[>3?:]&RD^:.I<ONOQGHPZM_SO.Y#"=)"DD6$P%D*LQ1,H0"AB*L?W 5<B(H
M58Y?.+2@C.S JP>!P0X^SGT-N-$G1_?U93_,>GL3]W=>&['AMMO(^GT\UT:L
MTW"MP0-E^:E85&SZW_RVWD6;:"X88@(4H11@HF>93&4$8$48#J%*8A)ZZ;(!
M,[(PE]B!!O<Z_L+:*$=A>M,?ILR^S/V%:24V7)G-M-]'FE9JG=JT1[N+\\\R
MKRHY-Y9\-U_ML5Q,TI3H.6LH08(3[9=11(%V2 %$!D,L<*P[R?OJTHIP8$FN
M,(,F:'\EVKNR7X2#N;KISY&FD^QV4O%2G#WC:&+;26A;9[L#W25FCO*;?KHI
MYNN51)3($#/.0"2465&%#!"5$,!E'$409AFBO5WO>?(#"ZN&"VH\YQ755A_V
MZVD(.S<I.1!SDE$7 R\%M9*-)IXN&MNZZ8SQ&#*NOHC_4S%C^7P2AB13$0\!
MQR@%F%(),AX*LR]92T6FB+'>^\*:J0\]--R<B[*$<SD4IMF"'@- ;V*.@[[>
MG-R&>=;R_89VS53C#>>L%!I#.'N$_^DM(<JN\FHJ)Q1!18AB $FJYT_4[%*F
M602RF%*6\5B@$+J>W+).?F"1U!A!H8(0_2O[=[!&=S^V9=.,_6(90M%-+J[L
MO,YK>4YCT%DMFV2CG]/RG(;MC)96C+MXUJ=4;PYF_8E5<L(AAQ#J.4]$(@BP
MPGI4EA$*$$=)B"7,$._]53 KPH%EM#E[>PD::-3 P/;7D;TO^\4TF*V;HIR)
M.DEJ)QDO7=DSCB:NG82V%;8[T'?=[VQNCGNO)U%F(?&LDK/%A'.B1)QB@)#4
M,R"JIT$$0@Q(PF.H9T$*0L=O1]M@QEGWVT(.OAKLH 9W/O_/VJB^ZWY#Z7NM
M^SDS]SK8MIO8H/-L+6E'/\:VFYKM]-H=T?X>>*7_="(1%0)G$L21.8\SC?34
MBF ,8D8D)I'*8M1[C\IVXK$<SV"YVUQ-O;^[N1+R-+6=7+R<;+OP0096)QK=
MM[;+M]E5X_4N(6QW5,OG[_>OUL_DR_\=X_VK_P-02P,$%     @ @82=6/TW
M%+2P!P  #SP  !0   !M960M,C R-# T,CE?<')E+GAM;-6;;5/<.!+'W_,I
MYKBW)T;/EE))MCB27%'+)E3"UF;OC4L/+7!EQJ9L$^#;7]LP"4/"K0M[:V;>
M@+%E=^O?/[?4LGCYR\UR,?L*=5-4Y:M]=D#W9U"&*A;E^:O]W\_>$;/_R^N]
MO9?_(.3SOS^>S-Y4X6H)93L[JL&U$&?717LQ:R]@]D=5?RF^NMGIPK6IJI>$
MO.YO.ZHN;^OB_**=<<KEJMGJ:OTB1IY1G1*14BDBHTW$V*2)U)H%<(:+"/\Z
M?R$M9<Q1O.BM(])81FQ&!?%1N"1H2#30_J&+HOSRHOOA70,S[%[9]'^^VK]H
MV\L7\_GU]?7!C:\7!U5]/N>4BOFJ]?Y]\YL?VE^+OC6SUL[[J]^:-L7/&N)C
MV?SS;R>?P@4L'2G*IG5EZ PTQ8NF/WE2!=?VJO^E7[,G6W1_D54STITBC!/!
M#FZ:N/]Z;S:[DZ.N%O 1TJS[_?O'XS632XA%<DW+#D*UG'<MYD<5$H&^]O>V
MMY?P:K\IEI<+6)V[J"&]VL<[21=3*KGM#/[S[K[Y=[N7-30(2]_/$SQQ?WMG
MY!D^P$T+982[CJU,+*JPUFC1R5I]NW/A/"SZLWF$(N^?>NB;MG:AS9EU.EA/
MB><^$*D2$*NL)C$E[YBG7JNPWN7.YP:=[J/00#@XK[[.\<'S3H?NH!>D%^,'
M<W?"/,_OMV5;M 4T9\XO(!>)@0E!$!N9)%( ^NTXOD%12Q\@4RG247ZOF5OW
M^V%(#^LPJ^H(-6:.E3U7AQ_"N\[L?8OYI:OQ021<%(NXNCO5U7**:+75%-K=
M10;]W9]AMQ/4-<23N\ \V;N^:RTF5.A;C@[Z[4G1M)B-F[<WX<*5YW!X4S2H
M!>/&X_OGA,=LZ((CSAA,G\X9ANE41VG'$_!3VYO#840@'^,P7M5-LW'O]YMJ
MZ8HRMUPH *6)\\KBNZ$C,5PSHEE2B5+(J$GC>%BSMV$&)HA>-8F4&X0 T.O\
M\_L_/^5,,QN=PI$?WP<BF?'$44Z)LU+B%0'!9 -BWSWP+OC=T??H?S.TP:"/
MB% U1JY-O^0][,=E-YU>S:'@N(5EDP=KK,PR1CPD[ 6"3KP$3[P!QTS(9+!3
M#  _LSV( [[M \!H53?,QJH0.\.V>:8P]<7 B!'=U,A)1;S*\,AG%GST7/$X
MBH:'UC:=_,='KII QBT)_RG4117?EO$-5N.Y<A!]P-'/6MU7T)8X%A4)D@&W
MH%6TTW"P9G;#">'O >+YPF[%H/$1SHNN;BK;]VX).=5": &2>*$BD=)R8K1,
M.&0"X]8RFZ298+A8MSJ("[$C7(R6=2NP.(P1P]#<_^I483E.C,%*&XB/#&?+
MP#-B@C=$1PK =&8S.[)V>,KT($#D3@$R5N!MHN0(#S_49]5UF?O,IP1 B>CF
MW9))S(3< U&!.Y9<$-Q/R,AWPX,(4;M(R#/%W28^/F$DX$-]6E=?BS) 'BAE
M."H*PJ/ NLQEDEC5'44IHC&BPWTZ2!Y9'T2*WD52QLB\3;B<5DWK%O\M+H^J
M"+D,AEO*L1=(.<ZP7<!>4$8R*E- C6)T>CI8UFP/0B7;152>+_&&0>FRX6$-
MKO=;\X05ET,!M,7"'KII-Z.4@&9!.RX5E6(4&@^M#8+![ @,SY9QP^'OOH4N
M3B^J$MY?+3W4>9 V8YXFDAG B;6/&;%1*>($"T)(;;0;5Z\\MC@( [LC&(R2
M<\,H?()P5:,@C/NSHEU SIG4B2M/@C$X.Q*9)IXE2YC6FBJ6>,S&#12/+0Y;
MWZ([PL(H/3?,PEGMNHTHGVZ7OEKDE!N<"/-$A!>8S[0"8L%EA -CV@4:#1WW
MM7[-W# *=F69\_E*;DDZ6'T"ZI==DN,JTB0(59W_*EKB:8A$.\? ITRXY"=)
M"0^M#@-B5Y8Y1^NZ82[^0.=;*(^JY?*J+.YV4J$:P<3((R=!!,QMO!OBC/?$
M>IZXUEY8X*/ ^*G9863LRD+G>&4WG3*J11&*;G_ ;U@XUX5;Y$9HI14605IW
ME9"%;ANAHL3R%&F07B@W[KO(CS:'0;$KBYLC-=TP$:<U=#A#&:#_UM?M(JP_
M)/0C-R9$B BR< %P*$R&&&NP4(Y.8#I,*J@AFR>>)N-IV\,(V97%S8DTWBY2
MCIOF"NJ'?0D\XTIR3;BE'O.@\T@]JA5L3$9(ZC(S;H3Y*P^&4;,K"YV3ZKT5
MBYUOEU"?8Y[\3UU=MQ?8N4M7WN:!)LY$![[0ADBF'#&H$A$9 RR^\8288,?N
MSXT/(V:WUCO'J[P5L!RA?K5;'"/O-[_";8Z@*YY$PMAFJ1M3 _$X\2*,46J4
M#@;[, $FC\P. V17UD#'*[MA- XQ$\8N&[Y;N/.<"<IDX)(PJ3C*P%RG ,.:
M3&$%;SBDD5/7-7/#4-B5==#G*[D5V>',W1Q']+Y(]V78_6HN[[:P,B6)X1[+
M=,YYMWR# V-*@3'L70AN@BSQA/EAN[UV97ET.J6W IEWQ6*UYF]32-I*1C*E
M!9'>)F*MB$12'03VB5$];J;ZV.(P,'9EQ724GEO!PG$9JOJRJGM!^DT$1]45
MCHJW_=?!2&4(&EGVJ?MGRY0)8B+'HBSS44B)4VLZQ??W_^O$,&)V94EU:M4G
M@^CE_ =]L;=?7N_=7^A^=/\_^GKO?U!+ P04    " "!A)U8CI2B4OTC  !!
MCP$ '@   &UE9&9I;F%L96%R;FEN9W-R96QE87-E,#0R+FAT;>U]:W?:R++H
M]_,K^DPR&6<=H4'B'6=G+1([LWUWXF0'SYE[[I>S&M% 3X3$J"4[S*^_5=62
M$"!LC V(1SX$@Z16=[VKNJKZ[3 <N>_>#@7OO?N/M_]9*K$+WXE&P@N9$P@>
MBAZ+E/0&[(^>4-]9J13?]<$?3P(Y&(;,+MM5]H<??)>W7%\/9>B*=\DX;W_5
MW]_^2B]YV_5[DW=O>_*6R=X_?I)VDSL.[]:K3K-6+7<%KPDNK'ZS5^XZW7JK
M^[^5VD_P+-RO'U+AQ!7_^&DDO=)0X 3>-.QQ>'XG>^'PC54N__P3W??NK1P-
M&'=#>,6(#X3YYWCP$U.!,_M=#Q8/5&^-?YR/>#" L;M^&/JC-S48^E8$H72X
M6^*N''AO0O$CC"\G;VTUQC_222Y,E1[0SSH #Q' K7T? !Q?=WS7#]Z\*-._
M<[Q2ZO.1="=O?OD CW4#^8NAN*=*2@2RKV]0\F_QQK)@=O3U+H8$/.]*3R20
ML>P:@..SZ,D^5R%K>YX?>8Y0[*,,X/N_(Q[ =#0&/TJ/>X[D+OLF5.2&BKW]
M%<?.+$A/&S 8O%NXEK/8/R,5ROYD8ZNMYJZV/0ZDR^R60<LJ[CS?MS_=7'W^
M\NV2O7K1M"WKG)TED\V;1JU><:Q-3./WSM7U9:?#_KCZ=GG?!#8%A]>ETB[6
MG3#%+I;,SJ[_IW/YZD6M><X^7UZ\-E@X% RDHQL.&?=Z[$ZXKB>48HX_&G-O
MPKY[_IW'^G[ )##FD'<EB""N0#CC[1]\[@Q+@TCVX =7]@6M@RG?C4+I>P;;
M+(#SI<Z7KS?M72#VOZ_:KUY8C>KY+C +F/1[?,(",?8#U)U!+$L1=8CD/@G>
MOV+!*SS$V&<>.$-6L;3$,A\E=K>K27+4QE(!.^:]'M@-)5?TPS>5.HR_*'+U
M3Q*@X(5O2E9S'&Y9"*/HM>L[()7S&?!8MEFKX.*_B5OA18+Y??82:-AL,'BC
M2SQ\)T$X!/'U,8"?.Z&\%4SPP$/[S$$A0 ]6C;I=.>'E.?%R!: 8"X+''-PW
M.\5\-F0/R=9-H05DJU8V8$("I54:1K-</E':<U+:M0B9]$#O:R'0-"N)",C5
MXEWN?!\$8-7W2O%T^_3O?--P._-\K_1;N_V5\1[B$O28-SOUAFDG4W]]HI'G
MI)%++7H4J8&>!"L/H*^&/!#L[-6+2O7\\FN'/E\3(LIFHUXHVF$YQ -3CB=;
MKY_(Y5G)Y0-70X/A_^SRKTC><A<@HPQR':Z\6_ 6*-S3$4X4R%!JV?[2JM7-
M:BI[R/KX6P0^ZXENN)^1 <)+^?PCAD+&W &B&X$3Z' 7I);GWW+TE9@$K@K\
M6XEP9 .*@*&IY: W%OKI$_I%S/7AY\3/@AN&W&-@H@6L*\#B%R;[0S!DRS"
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M-I)[0*":ALF5Y' 9<&8PX0TQ* R_=7U\^@XHD0)3H"&0O+OPK8\A*?B.<$C
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M7%&G'&J3(SW Y&"2&L8$,DQ%\'J&!A_]SST=G0U%]E>],:U_0%N9[&,E@0[
M@P2[M*=?@WZ>&.AZ?)@!O2KS;I-U]",NN)L]H9Q CN-NA],M-W#2_>Z?.O\2
M[7BL[Q<#*F\C8]U@ Y^CO^WKG7UZ,0\& L/)FEP #+CI Z2 OB7<[%,S1G0P
M]8[C$L FH,^ &@=(4]]HJSD*L,]>O%7/T^GKK>G4,\XL2#O[ ;:]HW51BR/L
MZB:IQR:U, VD^@X?>*@)74BS-32D^]S!-GX O[@I<:A)1/^<]*($*AJA8T#/
M*",+46P4J9O7406B)##1"W0O1T)<2*$(ZEHW#38<FQ\:!U= %K7.V54<WTA[
M*2;)"MA\,%N$F01VLE&@[/49UQ03N$5P*YWD-0N[S;'G"3?R'H73Z>2B)+?"
M<;D<D6E^C!U8TT#!+.SFB3SQSO'O. !'6$LPI9].,[V39I"9X;*@I_!"VE<2
MQA@$?#2#[5CH*I]\9\0W1PP=&W9FV$>7$&!Q 76<ZFM7./;HOHL)IDHJW_.$
M>S\N =XA"DY.^4%ALB4>)[9-M/34L95)%\MI0O"KXSG$UQ0AAFJG,2*9>9/.
M9RB%?BEIV,NZ>%(8$@2U6=7C]*0*HEA;@>C,#(!!)53%0YB<OC>F,>;*9!&:
M91=6B0H-M57:F!.)%8B;6K1J>E,9&DOV4ZFWW6*8-5LVK%]%) R$.8ZZ+FAU
MC&XM!\0L9U#V5EI&(GY(O9] #I%N4.3R.PWT0 RB)(?&]Q:E60)./7#?A9=$
M/$_OS^1K9?.\])-)70PAP$W-MWBI3CJBKHC'0':<XY-9$N)8_!4).CT,*9+T
MZT#X8Q]'Q+!<HI,QA0@SC#!QSA_%P;MX5IEN@VGA#?4511@E8//2%M! JB"-
MT@90"I4K"1(@51%X\?SP4E;^9!F )D7I-T*S BA_Z<9L10FE&%M'H1?XKLY^
MZJ>1/'V*#^WXM$&OZ#WYQ#J).] J'2&EPJ:,:6/,&$-HR"A84<P'@>B[<&?:
M5O%^JQ5-(,2?3TVK078"&'F4C(2[#11)U:D9J<'&$ 6Q?86\G!H]2<Z@QF \
M$FXH9%Z)>PO]" UELK6X&^E.N0+WS99.5:]FZH48V;T? !]:B((:^NIFNLB.
M;<^+Z,@YBB\#ZC^B1V&52__*5*$I)"_:=-$E86G^[2F1YE@3:9+,:R-K[4M7
MMX:3;B*F:0_.D]0C ,E493U*?#+U*G%#4.\?9*T3)-$X]==-3O5263+]MU:?
ML7,S?T.S]"\4'2DCWL/E"RX8"#O^'57V)$YQ)ZL G7'Z>\IFRPX,VV)^+=@-
M.;&2[4XC34R-YY.?HK*;/!1M6^QX,IT0E2'[?\+[+H(5Y[*I &V"K#2)F"*V
MHQA<<G:78$?P.JM6*Z]9I=$JU>Q:?<ED[H]LGM309M30(Z/*6S]UMZQ#Y5<?
MVYT;X/WK#Z %KB]8Y_?WG:N+J_:WJ\M.8>?]X<OUQ>5UY_*"P5^=+Y^N+MHW
M\*5S Q^?+Z]O.NS+1US2E\^7[.SWZ_;O%U=P??F13;M>SQGEX/30[0OB8A@_
M@@%[8*.+'XX8AU1YJ(_/XB,_0FVLCTGI24I8ZJ':Y8LK?/<VI'3NE&VQM7J)
M',RQ$F^2/\[!!<9\VS>2W.\2/;06,Y3+9EFS80B$'_:2-\>73;KT:]A;O%:K
MF-5::^GELFDMO7;?L%;5+%?K>S7L:D#XE0"L@0QX5&/N_>.GRD]3.4KG;+TI
M,XM.%TO&2V]M+=QJCW_@S><+[+" =W^\Y>VO&VJZ\=FGIAN7LTTW4J)_#JA,
M;UV:P+$'X)HY5OP)2SQ\,%7RJ&?.,K"J!(2G4Y26OIA0#_=B0K;LL61UCQAG
MHZ]\@($6T>TX0MR/;CSJ;YO(7K"5K>K/Z;G%\VSQF'6566%7]_))Z\JN)\!1
M=[\@JU$U&I76JQ=6O7S^E,4AW3]FD8^2=7/O6TM>/LQ !4')2U:I-HU6<QV%
MNXQQL@>A6A4SS\C<^CH_X"$.N.&'77174*/%QURU852KC4<LY1%:J+BKMLJV
M46OE:OA]5F^+S3"J<V?AK&7ZQ0M=R6(H L[SP6#9#<-NV4^!P',(\SV'HEVM
M&Y56>8NV\19OW90(**(J6^5XG>?@E2*0\A(E8+6,2FWG F$/ -6RC6:C=?*'
M#\X?SI?Q^2W/#T48Y*^Y8;2JY9,H> A,M8I1LZR3]B\H/^?+[R^48!(W\3R+
MSR1Y711B?_8Q#C#N<!4WCUP'B442*DOL"\.>B[8?00CBS&I:K[<2@"@B06].
M)!47X[91M4_>Q@J,\2BV>&X3O[B J1CU:NUYQ>2>0P1DJ)U++(\Q1G<?[=NU
M%?7LKF^!+.+'>+BLBR7!(E%+(?^Q=YL\2T+?EE%K/K/H*/ZJP5>MV$^.6NVG
M#W3RHW))XBMV'%/)249[S.?++ 2[WCI<-E_B/0*;UY\<DMI/%BT F^]<S%^G
M!]2LXEOMB\&;O]:73:-BU9_ X8\%0R'RVI; 8EGJU\IK*R""*RVC54_3J+8I
M1N]/IWL$VSP^I:YHXOKDM!5R&^.2!QZ5R$XK7DIT"JJSA&H+)\@>EZ!;'%F5
M/V\\U?%>J;&A7-L'=-L)ZYOU,<QZ<[-8/ZF#DSI85QW$AYN=%,))(9RPOC6%
MT#@IA)-"V+GO_ =]P<,"L(?70"2G=6<.8MY,;/24<#:'B?=Y3MEA92E89:-5
M7B76?N39' "G9KVZ3D)'8:G[(M_&W.=H\W(:KS5/&2=SY-PJ]I[RR3HII-3X
M@ >V)SUY\ @RQZ4SWE/O=75Y$K?=V4?^><F>;?-J)2CLH;_WJ.45$,666:^M
MLIFT*A6OZ2_^2IVJWJW>TNO4#*\@/5E/#>^>WO#N??M3^_K#)>O\\_+RIG,P
MK>YXP+"?L]CO=G9-L]%<?GGM!G$MTRJOUR7O_FN55O/Y)]LT;:NRE6YV*]F(
M1>@[1F(H:5V'_:&WELE7E-6GK='S '"J.#^$@&%^Z+;=Z8":*DHT;=LIENLT
M2EQ(L:YO-[\Z'X\?XE;R;:5$N%['@ WTF7SV,;92J6D7(6&>HA9T2 #^(?Z*
M)-A?,V<+SOEVIV:)Q?+&6PVCVK!.O1*+@Y&7K%4UJH_:$GD6!5$,@8)G)WBA
M'\B52F[667A!T%RM&W9CE:X&NVJU7! XU:I&K95;OG,$ZE6?)#+*4ZB')?1J
M3:-56Z7-Z)$KAUK-J)>?R U[K!NF]9@&'G\WYG*E;?8]EGYHG9V4Q$-@:AH-
MNW&D.N*KY@,6-\G)GA"=G-S&UW>W]T8R6I91M4[M<QZ&4]FH-W+[\VY6@S2+
M$'^Z\4,\$/7I;!%#8&^RE98T:[9:1JVY\_->]AV*=M4HGQJ)G,+?*ZAJ;"84
M3@PZXUL?^XPQTS$=,%QBG@CU4=5.-,+#LT4/3TH/!)[-+7WOP$W=LM%JKM*[
MX,AMW1H8.O7M&[N%8*!O^'?)[Y<B)8[#JJT:M<IZ3'%<5FUMH?GAT6@5W2OU
MZ<;L'F 96URN4G!PY"H"I$:]]D0?;U]5Q(7HBP 3YT/^XRA4!#@?Y55Z-QZY
MAJ@:EI5K-3W-1]NV&[SK?)?B)*45,+KTY:;]B>7GJNU=_LLCFZH5/_]E24.U
MLFTT:FGP9IL2:;^3;DX$752";AFM<@%;!&Z,H$]Z?*_U^,XYYM-5^_W5IZN;
MJ\N.KNNZ^?+A7__\\NGB\EOG%W;Y[]^O;OZG*/;U*?;^U-3S3Y)WI2O#9THP
MW#4?'WG^>=MQ8!VA8F,^H?H^.J34<8)(3#,B]MX6/Y)<] 8>]-4ZF<4%0,7!
MT5:S;E2M!_H.;-I"/8(4S43+NH(KP?PN3.,)I\/N3<"]MF(CI"/?EZ@9S>83
M-^GV-S@XDWKF/M$*?4R;I"+0PY)#E1N&U=QYUO^> [%E&Y5R[F9?82(BA1[C
M>)RE3_-*V4@RSIQG5=M[LR>(^^36>N451[5W:M4-ZZGU%7N>,_Y4A7T8J<XM
MRVBT=F[H[CD0K7+3J.:STRE?_!2SSE!*)_2=[T/?!6I7O[#+OR(93G;-?"<[
M[.E!$G\T\CUX&V#7F#:M8R^Q99PU[?CZZD6M><[LL@'32)K5\R@<^@&\K =7
M6PNAK$+PY[[P^+;MB^5=M"L-VKB@[M%U)I7"[0NJXWS4V00GQB\VJGG(9AKX
M50G'\UWM*@8#3A\+!UO'NNL)_/UQ+4[NUV-A=#R["6V8,(8AP/_"$G>8''/X
M6((_=MC;"7;#:-5/O8$>AE/=J,WU4#H>*[*=J1*-VSWXHW$@AL)3H#@><>;U
M_DI&^]3PX6$8S55,'8_Z^"9"#C_VF(B/@CQLK6$U;5 ;ZY4"'97:L!I5HU[-
M;=AP4$[(??%L-1-:$NN'E@YC$]5&+[R^<U]DWZ%8MHQJ,]=;*<Q>]"D[?[^R
M\W51W3HY^BLRV_Z<$_5,%4S[<X#4@93L;?Q JRWE+I\89E\99L]* G=T MQ]
MY[RM>VW.[CF=#_?,Y\,]C)<M<)E= X!<^U[IMW;[*_LH/>XY$IRLSX*K*,AD
M#-USIMJ?D0IE?[(]5Y@F?>4Q[C'@.3\(6>BS<>#C":1,4N-Q/U#L3H9#QJ>!
M>.G!O2/*#F2!&/  .9&%0T'A1^Y-7KUHVE;C7.$F5N2&RF#9JZPGE>/ZV*?V
ME@?2CQ3S$L#U4\"-8L#A,6\R5.ROB = I.XD#>5@^V>%[] IB].>M^.HZTHG
M>0T.8K(;>'_?=UW_#N>Z[%U#?BM85PB/QL8CKV!,@@]7  %$$/S2Y4HJO3/?
M^>W5BTKSO)T6FAEQT)7U W_$L-=?DF>IYQ9?/8OO?VUH>"N$)4 UN1XWN,;<
MS/@77%Y/'RO-+K]V3';)G2$F;L*PL/K[("A^.&[4@S\0"1)PX.B,3^ W#M#E
M(UT_![B7'N"8AS$PD\D#E?TMZ.%/LB\^7Z"EX7*0T)H$\-[( SF"M_78 ,94
M"#69=JY''*:/3A,?$*C]*-!PP?"([$L$KP LT:B$#L\/-4I -#AQL!MG[3B@
M(F"I0M,G+MYD;2 'QX?UN[I?(JY3K PHA   8N2K4!-K0 6%^;<SB;1)D(WG
M3%3VP"MXH%<D@;8\?!+>&8BQRYUE[U'FXV7'_8IHYR+G)B,,(J4)\P&X(;P"
MH$3@?X"8P&R9A$Y'W -%DY4POZ@,YP%N'([- B72D2O%K7[A))5T<+$?N4Q%
MX[$KD%Y7D7'X#J\T\/%G)#E_!"('7DJ/ 55JD9.L<@BD[@Q!YGE9$1L.B8:F
M;R(63,0NKM,C H37CN@Y/3P0*% 1@ ;%(,Y<TZI4N%H@]'CM,+%8_NJ26/B@
MA_3(HS',*>'KY#Y\.%G4%(*'28!3;4!&H$HEAP;)_<08LST=02I3'40ZX60;
M[HEMF$.-IW.%GWZN\/67:\TXAW*B<)*+F1A*>WVRL-TR:^4-'-9KF=7R!@XL
M;I@5>[T#BQ\X6KANK7?6\0.SK=?LYSBQ>/V=!<M^TO9L$8[YU0HZ$&#BP'U#
M\%_(4)Y-FWS6?(;G.HFWP !%B;S*UN:>+_/WJ1_Z&_JV8%-?Y;FA<?X]55<<
M 5CB52?G!'5$<"L=,&3;X$F$\N^5CQ;8<S D\;FMI'WL,L>%5ML1+OPX,-A
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M9"TR,#(T,#0R.2YX<V102P$"% ,4    " "!A)U8L8,M\00(  "'.0  %
M            @ %+$@  ;65D+3(P,C0P-#(Y7V1E9BYX;6Q02P$"% ,4
M" "!A)U8QNR*,ND+  #M9   %               @ &!&@  ;65D+3(P,C0P
M-#(Y7VQA8BYX;6Q02P$"% ,4    " "!A)U8_3<4M+ '   //   %
M        @ &<)@  ;65D+3(P,C0P-#(Y7W!R92YX;6Q02P$"% ,4    " "!
MA)U8CI2B4OTC  !!CP$ '@              @ %^+@  ;65D9FEN86QE87)N
H:6YG<W)E;&5A<V4P-#(N:'1M4$L%!@     &  8 C@$  +=2      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>med-20240429_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:exch="http://xbrl.sec.gov/exch/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="med-20240429.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <startDate>2024-04-29</startDate>
            <endDate>2024-04-29</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-29</startDate>
            <endDate>2024-04-29</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-21">0000910329</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-22">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2024-04-29</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">MEDIFAST, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-31573</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">13-3714405</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">100 International Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Baltimore</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">MD</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">21202</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">410</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">581-8042</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-13">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-14">MED</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-2" id="f-15">NYSE</dei:SecurityExchangeName>
    <dei:WrittenCommunications contextRef="c-1" id="f-16">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-17">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-18">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-19">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
